2015 Q4 Form 10-K Financial Statement
#000114420416088262 Filed on March 15, 2016
Income Statement
| Concept | 2015 Q4 | 2014 Q4 | 2014 Q3 |
|---|---|---|---|
| Revenue | $338.0K | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $7.210M | $3.200M | $2.740M |
| YoY Change | 125.31% | 7.74% | 28.04% |
| % of Gross Profit | |||
| Research & Development | $5.760M | $1.770M | $1.609M |
| YoY Change | 225.42% | -72.98% | -69.99% |
| % of Gross Profit | |||
| Depreciation & Amortization | $10.00K | $0.00 | $6.000K |
| YoY Change | -100.0% | ||
| % of Gross Profit | |||
| Operating Expenses | $12.96M | $4.960M | $4.346M |
| YoY Change | 161.29% | -47.9% | -18.93% |
| Operating Profit | -$12.96M | -$4.961M | -$4.346M |
| YoY Change | 161.32% | -47.91% | -42.08% |
| Interest Expense | -$2.450M | $1.250M | $121.0K |
| YoY Change | -296.0% | -562.96% | -75.46% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$246.0K | ||
| YoY Change | |||
| Pretax Income | -$15.08M | -$3.710M | -$4.590M |
| YoY Change | 306.47% | -62.14% | -41.38% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$12.04M | -$3.713M | -$4.592M |
| YoY Change | 224.16% | -62.1% | -41.37% |
| Net Earnings / Revenue | -3560.95% | ||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$305.0K | -$99.30K | -$127.4K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 47.13M shares | 44.31M shares | 44.31M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2015 Q4 | 2014 Q4 | 2014 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $98.20M | $73.92M | $71.60M |
| YoY Change | 32.84% | -25.71% | -32.64% |
| Cash & Equivalents | $98.18M | $49.76M | $71.59M |
| Short-Term Investments | $24.16M | $100.0K | |
| Other Short-Term Assets | $1.600M | $700.0K | $400.0K |
| YoY Change | 128.57% | 40.0% | 33.33% |
| Inventory | $0.00 | ||
| Prepaid Expenses | |||
| Receivables | $0.00 | ||
| Other Receivables | $200.0K | ||
| Total Short-Term Assets | $99.94M | $70.46M | $72.07M |
| YoY Change | 41.83% | -29.56% | -32.36% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $309.0K | $52.00K | $58.00K |
| YoY Change | 494.23% | -88.37% | -87.17% |
| Goodwill | $0.00 | ||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $250.0K | $250.0K | $300.0K |
| YoY Change | 0.0% | ||
| Other Assets | $43.00K | $64.00K | $181.0K |
| YoY Change | -32.81% | -38.46% | 66.06% |
| Total Long-Term Assets | $18.67M | $18.86M | $15.94M |
| YoY Change | -1.0% | 3323.23% | 2740.46% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $99.94M | $70.46M | $72.07M |
| Total Long-Term Assets | $18.67M | $18.86M | $15.94M |
| Total Assets | $118.6M | $89.33M | $88.01M |
| YoY Change | 32.78% | -11.19% | -17.83% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.868M | $366.0K | $333.0K |
| YoY Change | 410.38% | -21.79% | -70.11% |
| Accrued Expenses | $8.570M | $3.683M | $3.200M |
| YoY Change | 132.69% | -16.86% | 36.05% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | ||
| YoY Change | -100.0% | ||
| Total Short-Term Liabilities | $10.58M | $4.077M | $3.557M |
| YoY Change | 159.48% | -63.63% | -63.12% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $23.20M | $14.00M | $14.00M |
| YoY Change | 65.71% | 100.0% | 66.67% |
| Other Long-Term Liabilities | $584.0K | $722.0K | $793.0K |
| YoY Change | -19.11% | -32.96% | -48.54% |
| Total Long-Term Liabilities | $584.0K | $722.0K | $1.181M |
| YoY Change | -19.11% | -32.96% | -23.36% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $10.58M | $4.077M | $3.557M |
| Total Long-Term Liabilities | $584.0K | $722.0K | $1.181M |
| Total Liabilities | $34.34M | $18.80M | $18.75M |
| YoY Change | 82.62% | -2.6% | -4.32% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$190.2M | -$141.7M | -$138.0M |
| YoY Change | 34.17% | 16.8% | 23.73% |
| Common Stock | $47.00K | $46.00K | $44.00K |
| YoY Change | 2.17% | 15.0% | 25.71% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $56.85M | $70.52M | $69.26M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $118.6M | $89.33M | $88.01M |
| YoY Change | 32.78% | -11.19% | -17.83% |
Cashflow Statement
| Concept | 2015 Q4 | 2014 Q4 | 2014 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$12.04M | -$3.713M | -$4.592M |
| YoY Change | 224.16% | -62.1% | -41.37% |
| Depreciation, Depletion And Amortization | $10.00K | $0.00 | $6.000K |
| YoY Change | -100.0% | ||
| Cash From Operating Activities | $2.860M | -$3.520M | -$2.720M |
| YoY Change | -181.25% | -50.7% | -62.33% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$190.0K | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $29.49M | -$22.67M | -$50.00K |
| YoY Change | -230.08% | 15013.33% | |
| Cash From Investing Activities | $29.30M | -$22.67M | -$50.00K |
| YoY Change | -229.25% | -162.5% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 40.46M | 4.370M | -1.440M |
| YoY Change | 825.86% | 1020.51% | -103.16% |
| NET CHANGE | |||
| Cash From Operating Activities | 2.860M | -3.520M | -2.720M |
| Cash From Investing Activities | 29.30M | -22.67M | -50.00K |
| Cash From Financing Activities | 40.46M | 4.370M | -1.440M |
| Net Change In Cash | 72.62M | -21.82M | -4.210M |
| YoY Change | -432.81% | 223.26% | -110.97% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $2.860M | -$3.520M | -$2.720M |
| Capital Expenditures | -$190.0K | $0.00 | $0.00 |
| Free Cash Flow | $3.050M | -$3.520M | -$2.720M |
| YoY Change | -186.65% | -51.71% | -62.74% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1868000 | USD |
| CY2015Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
27000 | USD |
| CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
8570000 | USD |
| CY2015Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
584000 | USD |
| CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
47000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
46000 | USD |
| CY2015Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
246955000 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
212205000 | USD |
| CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-190156000 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-141728000 | USD |
| CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
118610000 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
89325000 | USD |
| CY2015Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
20002000 | USD |
| CY2015Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
14586000 | USD |
| CY2014Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
14586000 | USD |
| CY2015Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
2485000 | USD |
| CY2014Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
4160000 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1250000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
0 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
56846000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
70523000 | USD |
| CY2015Q4 | us-gaap |
Minority Interest
MinorityInterest
|
27427000 | USD |
| CY2014Q4 | us-gaap |
Minority Interest
MinorityInterest
|
0 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
84273000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
70523000 | USD |
| CY2015 | fbio |
Percentage Of Tax Benefit Likely Of Being Realized
PercentageOfTaxBenefitLikelyOfBeingRealized
|
0.5 | pure |
| CY2015 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
11408000 | USD |
| CY2015 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
200000 | USD |
| CY2015 | us-gaap |
Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
|
32882000 | USD |
| CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9889452 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9058167 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5090171 | shares |
| CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
366000 | USD |
| CY2014Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
28000 | USD |
| CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3683000 | USD |
| CY2014Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
722000 | USD |
| CY2014 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
9000 | USD |
| CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
14291000 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5546000 | USD |
| CY2015Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
24009000 | USD |
| CY2014Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
14009000 | USD |
| CY2015Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
835000 | USD |
| CY2014Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
6000 | USD |
| CY2015 | us-gaap |
Interest Expense
InterestExpense
|
1484000 | USD |
| CY2014 | us-gaap |
Interest Expense
InterestExpense
|
1338000 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
1923000 | USD |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
377000 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
94000 | USD |
| CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
68000 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
42000 | USD |
| CY2015 | us-gaap |
Depreciation
Depreciation
|
26000 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
23000 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
17000 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable Current
CapitalLeasesFutureMinimumPaymentsReceivableCurrent
|
500000 | USD |
| CY2015 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
166000 | USD |
| CY2014 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
154000 | USD |
| CY2015Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
2500000 | EUR |
| CY2015Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
2492000 | USD |
| CY2014Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
598000 | USD |
| CY2015Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
382000 | USD |
| CY2014Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
837000 | USD |
| CY2015Q4 | fbio |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
810000 | USD |
| CY2014Q4 | fbio |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
832000 | USD |
| CY2015Q4 | fbio |
Other Short Term Liabilities Related To Manufacturing Rights
OtherShortTermLiabilitiesRelatedToManufacturingRights
|
1500000 | USD |
| CY2014Q4 | fbio |
Other Short Term Liabilities Related To Manufacturing Rights
OtherShortTermLiabilitiesRelatedToManufacturingRights
|
1000000 | USD |
| CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
523000 | USD |
| CY2014Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
213000 | USD |
| CY2015Q4 | fbio |
Other Long Term Liabilities Related To Manufacturing Rights
OtherLongTermLiabilitiesRelatedToManufacturingRights
|
0 | USD |
| CY2014Q4 | fbio |
Other Long Term Liabilities Related To Manufacturing Rights
OtherLongTermLiabilitiesRelatedToManufacturingRights
|
334000 | USD |
| CY2015Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
493000 | USD |
| CY2014Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
120000 | USD |
| CY2015Q4 | fbio |
Lease Abandonment Non Current
LeaseAbandonmentNonCurrent
|
91000 | USD |
| CY2014Q4 | fbio |
Lease Abandonment Non Current
LeaseAbandonmentNonCurrent
|
268000 | USD |
| CY2015Q4 | us-gaap |
Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
|
0 | USD |
| CY2014Q4 | us-gaap |
Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
|
38000 | USD |
| CY2015Q4 | fbio |
Lease Impairment Current
LeaseImpairmentCurrent
|
146000 | USD |
| CY2014Q4 | fbio |
Lease Impairment Current
LeaseImpairmentCurrent
|
165000 | USD |
| CY2015 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
14291000 | USD |
| CY2014 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
5546000 | USD |
| CY2013 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
5902000 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2164365 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2015 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
100000 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
285000 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1779365 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
1067168 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.69 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.15 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
7.57 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
666396000 | USD |
| CY2015 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
24000 | USD |
| CY2014 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
141000 | USD |
| CY2015 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company’s consolidated financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value of stock options and warrants, stock-based compensation, common stock issued to acquire licenses, investments, accrued expenses, provisions for income taxes and contingencies. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates. </font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"> Reclassifications</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company reclassified debt issuance costs from other assets to notes payable, long-term on the Consolidated Balance Sheets for all periods presented pursuant to the early adoption of Accounting Standards Update (“ASU”) No. 2015-03 <i>Simplifying the Presentation of Debt Issuance Costs</i>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2015Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
114000 | USD |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47147032 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
46494034 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
46494034 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47147032 | shares |
| CY2014 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
634000 | USD |
| CY2013 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
536000 | USD |
| CY2015 | us-gaap |
Profit Loss
ProfitLoss
|
-53883000 | USD |
| CY2014 | us-gaap |
Profit Loss
ProfitLoss
|
-20386000 | USD |
| CY2013 | us-gaap |
Profit Loss
ProfitLoss
|
-37158000 | USD |
| CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
26000 | USD |
| CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
23000 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
17000 | USD |
| CY2015 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
167000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
195000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
|
0 | USD |
| CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
283000 | USD |
| CY2015 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
314000 | USD |
| CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5902000 | USD |
| CY2015 | fbio |
Change In Fair Value Of Short Term Investments
ChangeInFairValueOfShortTermInvestments
|
-1675000 | USD |
| CY2014 | fbio |
Change In Fair Value Of Short Term Investments
ChangeInFairValueOfShortTermInvestments
|
942000 | USD |
| CY2013 | fbio |
Change In Fair Value Of Short Term Investments
ChangeInFairValueOfShortTermInvestments
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
-398000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-464000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
0 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-20378000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-16334000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-29646000 | USD |
| CY2015 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
0 | USD |
| CY2014 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
346000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
0 | USD |
| CY2015 | us-gaap |
Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
|
0 | USD |
| CY2014 | us-gaap |
Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
|
2925000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
40000 | USD |
| CY2015 | us-gaap |
Payments For Capital Improvements
PaymentsForCapitalImprovements
|
0 | USD |
| CY2014 | us-gaap |
Payments For Capital Improvements
PaymentsForCapitalImprovements
|
0 | USD |
| CY2013 | us-gaap |
Payments For Capital Improvements
PaymentsForCapitalImprovements
|
148000 | USD |
| CY2015 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
| CY2014 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
13654000 | USD |
| CY2013 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1345000 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3502000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
91337000 | USD |
| CY2015 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
216000 | USD |
| CY2014 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
596000 | USD |
| CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
970000 | USD |
| CY2015 | fbio |
Proceeds From Issuance Of Common Stock Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockEmployeeStockPurchasePlan
|
59000 | USD |
| CY2014 | fbio |
Proceeds From Issuance Of Common Stock Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockEmployeeStockPurchasePlan
|
19000 | USD |
| CY2013 | fbio |
Proceeds From Issuance Of Common Stock Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockEmployeeStockPurchasePlan
|
92000 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
57817000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | USD |
| CY2015 | us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
6321000 | USD |
| CY2014 | us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
0 | USD |
| CY2013 | us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
0 | USD |
| CY2015 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
| CY2014 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
32000 | USD |
| CY2013 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1898000 | USD |
| CY2015 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
14009000 | USD |
| CY2013 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | USD |
| CY2015 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
| CY2013 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
| CY2015 | us-gaap |
Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
|
10000000 | USD |
| CY2014 | us-gaap |
Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
|
0 | USD |
| CY2014Q1 | us-gaap |
Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
|
0.35 | pure |
| CY2015 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.04 | pure |
| CY2015 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
118000 | USD |
| CY2014 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
83000 | USD |
| CY2013 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
107000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
2791000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
2779000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
2714000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
2733000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-10155000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
89156000 | USD |
| CY2015 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1250000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | USD |
| CY2013 | us-gaap |
Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
|
0 | USD |
| CY2015 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
855000 | USD |
| CY2014 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | USD |
| CY2013 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
14586000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
99521000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
40199000 | USD |
| CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
48423000 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-49762000 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
59322000 | USD |
| CY2015 | us-gaap |
Interest Paid
InterestPaid
|
80000 | USD |
| CY2014 | us-gaap |
Interest Paid
InterestPaid
|
785000 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
1387000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
4000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
4000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
60916000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | USD |
| CY2015 | fbio |
Issuance Of Common Stock For License Expenses
IssuanceOfCommonStockForLicenseExpenses
|
-958000 | USD |
| CY2014 | fbio |
Issuance Of Common Stock For License Expenses
IssuanceOfCommonStockForLicenseExpenses
|
0 | USD |
| CY2013 | fbio |
Issuance Of Common Stock For License Expenses
IssuanceOfCommonStockForLicenseExpenses
|
0 | USD |
| CY2015 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
79947000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
20002000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
0 | USD |
| CY2015 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
99949000 | USD |
| CY2014 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
0 | USD |
| CY2013 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
0 | USD |
| CY2015 | us-gaap |
Proceeds From Mortgage Deposits
ProceedsFromMortgageDeposits
|
22000 | USD |
| CY2014 | us-gaap |
Proceeds From Mortgage Deposits
ProceedsFromMortgageDeposits
|
0 | USD |
| CY2013 | us-gaap |
Proceeds From Mortgage Deposits
ProceedsFromMortgageDeposits
|
0 | USD |
| CY2014 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
400000 | USD |
| CY2015Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
14600000 | USD |
| CY2015Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
800000 | USD |
| CY2014Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
6000 | USD |
| CY2014Q4 | us-gaap |
Trading Securities Cost
TradingSecuritiesCost
|
20002000 | USD |
| CY2014 | us-gaap |
Trading Securities Unrealized Holding Gain
TradingSecuritiesUnrealizedHoldingGain
|
0 | USD |
| CY2014 | us-gaap |
Trading Securities Unrealized Holding Loss
TradingSecuritiesUnrealizedHoldingLoss
|
0 | USD |
| CY2014Q4 | us-gaap |
Trading Securities
TradingSecurities
|
20002000 | USD |
| CY2015Q1 | fbio |
Agreement Description Terms
AgreementDescriptionTerms
|
issue annually to the Company, on the anniversary date of the Founders Agreement, shares of common stock equal to 2.25% of the fully-diluted outstanding equity of Avenue at the time of issuance; (ii) pay an equity fee in shares of Avenue common stock, payable within five (5) business days of the closing of any equity or debt financing for Avenue or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when Fortress no longer has majority voting control in Avenues voting equity, equal to two and one half percent (2.50%) of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to four and one half percent (4.5%) of our annual net sales, payable on an annual basis, within ninety (90) days of the end of each calendar year. In the event of a change in control (as it is defined in the Founders Agreement), the Company will pay a one-time change in control fee equal to five (5x) times the product of (i) monthly net sales for the twelve (12) months immediately preceding the change in control and (ii) four and one-half percent (4.5%). | |
| CY2014Q1 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
250000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
28403000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four And Five Years
OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
|
2775000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
42195000 | USD |
| CY2014Q4 | us-gaap |
Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
|
11.50 | |
| CY2015 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.001 | pure |
| CY2014Q4 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
2700000 | USD |
| CY2015 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
0.093 | pure |
| CY2015Q4 | us-gaap |
Share Price
SharePrice
|
2.93 | |
| CY2014Q4 | us-gaap |
Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
|
100000 | USD |
| CY2014 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
354000 | USD |
| CY2015Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
82000 | USD |
| CY2015Q4 | us-gaap |
Land Subject To Ground Leases
LandSubjectToGroundLeases
|
6100 | sqft |
| CY2015Q4 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
214000 | USD |
| CY2015 | us-gaap |
Investments In And Advances To Affiliates At Fair Value Period Increase Decrease
InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease
|
1200000 | USD |
| CY2014Q4 | us-gaap |
Investment Owned At Fair Value
InvestmentOwnedAtFairValue
|
3900000 | USD |
| CY2015Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
100000 | USD |
| CY2015Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
2800000 | USD |
| CY2015Q4 | us-gaap |
Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
|
2485000 | USD |
| CY2014Q4 | us-gaap |
Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
|
4160000 | USD |
| CY2014Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
24162000 | USD |
| CY2013Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
0 | USD |
| CY2015Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
2485000 | USD |
| CY2014Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
4160000 | USD |
| CY2014 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
|
3218000 | USD |
| CY2014 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
|
942000 | USD |
| CY2015 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
|
-1675000 | USD |
| CY2015 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
114000 | USD |
| CY2014 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2013 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
7700000 | shares |
| CY2015 | fbio |
Fair Value Assumption Historical Volatility Rate
FairValueAssumptionHistoricalVolatilityRate
|
0.8 | pure |
| CY2015 | fbio |
Fair Value Assumptions Implied Volatility Rate
FairValueAssumptionsImpliedVolatilityRate
|
0.2 | pure |
| CY2015 | fbio |
Share Based Compensation Arrangement By Share Based Payment Award Contractual Term Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermOfAward
|
P10Y | |
| CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3300000 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
6900000 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
4000000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
66000 | USD |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
11600000 | USD |
| CY2015 | us-gaap |
Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
|
0.256 | pure |
| CY2015Q4 | us-gaap |
Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
|
0.1845 | pure |
| CY2015Q4 | fbio |
Working Capital
WorkingCapital
|
500000 | USD |
| CY2015Q4 | fbio |
Working Capital Committed
WorkingCapitalCommitted
|
200000 | USD |
| CY2015 | fbio |
Percentage Of Placement Agent Fee
PercentageOfPlacementAgentFee
|
0.10 | pure |
| CY2015 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
57800000 | USD |
| CY2015 | fbio |
Net Proceeds From Issuance Of Warrants
NetProceedsFromIssuanceOfWarrants
|
51500000 | USD |
| CY2015 | fbio |
Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
|
10000 | shares |
| CY2015Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2500 | |
| CY2015Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
7.00 | shares |
| CY2015 | fbio |
Warrant Purchase Price Per Unit
WarrantPurchasePricePerUnit
|
50000 | USD |
| CY2013 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD |
| CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-48428000 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20386000 | USD |
| CY2015Q1 | fbio |
Agreement Description Terms
AgreementDescriptionTerms
|
(i) issue annually to the Company, on the anniversary date of the Founders Agreement, shares of Checkpoint common stock equal to two and one half percent (2.50%) of the fully-diluted outstanding equity of Checkpoint at the time of issuance; (ii) pay an equity fee in shares of Checkpoint common stock, payable within five (5) business days of the closing of any equity or debt financing for Checkpoint or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when the Company no longer has majority voting control in Checkpoints voting equity, equal to 2.25% of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to 4.5% of its annual net sales, payable on an annual basis, within 90 days of the end of each calendar year. In the event of a change in control (as defined in the Founders Agreement), the Company will pay a one-time change in control fee equal to five times (5x) the product of (i) monthly net sales for the 12 months immediately preceding the change in control and (ii) 4.5%. | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
1950000 | shares |
| CY2015 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
158000 | USD |
| CY2014 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | USD |
| CY2013 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
7885000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-23273000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-188000 | USD |
| CY2015 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2016-06-30 | |
| CY2015Q4 | fbio |
Lease Expiration Period
LeaseExpirationPeriod
|
P5Y | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.37 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
3.69 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y4M17D | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P6Y3M25D | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P5Y10M6D | |
| CY2014Q3 | us-gaap |
Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
|
293000 | USD |
| CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable In Two Years
CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears
|
500000 | USD |
| CY2015Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
250000 | USD |
| CY2014Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
250000 | USD |
| CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015 | fbio |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
|
0 | USD |
| CY2015 | fbio |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue
|
64000000 | USD |
| CY2015 | fbio |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue
|
42200000 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
633046000 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
8660280 | shares |
| CY2015 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-5455000 | USD |
| CY2015Q4 | fbio |
Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
|
0.85 | pure |
| CY2015 | fbio |
Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
|
27000 | USD |
| CY2014 | fbio |
Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
|
25000 | USD |
| CY2013 | fbio |
Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
|
46000 | USD |
| CY2015 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1M6D | |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37158000 | USD |
| CY2015 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.24 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
366666 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
333334 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
1250000 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1500000 | shares |
| CY2015Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3000000 | USD |
| CY2014 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
4000000 | USD |
| CY2015 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
700000 | USD |
| CY2015 | us-gaap |
Revenue From Related Parties
RevenueFromRelatedParties
|
590000 | USD |
| CY2014 | us-gaap |
Revenue From Related Parties
RevenueFromRelatedParties
|
0 | USD |
| CY2013 | us-gaap |
Revenue From Related Parties
RevenueFromRelatedParties
|
0 | USD |
| CY2015 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
863000 | USD |
| CY2014 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | USD |
| CY2013 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | USD |
| CY2015 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
273000 | USD |
| CY2014 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
0 | USD |
| CY2013 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
0 | USD |
| CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18402000 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
10239000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
25682000 | USD |
| CY2014 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
0 | USD |
| CY2013 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
0 | USD |
| CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21584000 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10413000 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10098000 | USD |
| CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
51394000 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
20652000 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
35780000 | USD |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-50531000 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20652000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-35780000 | USD |
| CY2015 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
245000 | USD |
| CY2014 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
662000 | USD |
| CY2013 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
545000 | USD |
| CY2015 | fbio |
Accretion And Interest Expenses
AccretionAndInterestExpenses
|
1484000 | USD |
| CY2014 | fbio |
Accretion And Interest Expenses
AccretionAndInterestExpenses
|
1338000 | USD |
| CY2013 | fbio |
Accretion And Interest Expenses
AccretionAndInterestExpenses
|
1923000 | USD |
| CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
438000 | USD |
| CY2014 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2013 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2015 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3352000 | USD |
| CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
266000 | USD |
| CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1378000 | USD |
| CY2014 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.56 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.22 | |
| CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
39146589 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36323596 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
30429743 | shares |
| CY2012Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
22033000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
970000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
216000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
596000 | USD |
| CY2013 | fbio |
Exercise Of Warrants
ExerciseOfWarrants
|
1000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
3502000 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
14291000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | USD |
| CY2015 | fbio |
Adjustments To Additional Paid In Capital Subsidiary Public Offering
AdjustmentsToAdditionalPaidInCapitalSubsidiaryPublicOffering
|
51496000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
92000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
19000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
59000 | USD |
| CY2015 | fbio |
Adjustments To Additional Paid In Capital Stock Issued For License Expenses
AdjustmentsToAdditionalPaidInCapitalStockIssuedForLicenseExpenses
|
958000 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
613000 | USD |
| CY2013 | fbio |
Issuance Of Common Stock For At Market Offering
IssuanceOfCommonStockForAtMarketOffering
|
91337000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
1899000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
5902000 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
5546000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
81278000 | USD |
| CY2014 | fbio |
Adjustments To Additional Paid In Capital Stock Issued At Market Offering Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedAtMarketOfferingIssuanceCosts
|
32000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | USD |
| CY2015 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
| CY2014 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
722000 | USD |
| CY2013 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
895000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
139000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
117000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
5889000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-849000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1184000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-1000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-81000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-10000 | USD |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.01 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.02 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.01 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.45 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.4 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2015Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
500000 | USD |
| CY2015Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | USD |
| CY2015Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
25000 | USD |
| CY2015Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
338000 | USD |
| CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12571000 | USD |
| CY2014Q3 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-246000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
54249000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
38974000 | USD |
| CY2015Q4 | fbio |
Deferred Tax Assets Amortization Of Upfront Fees
DeferredTaxAssetsAmortizationOfUpfrontFees
|
4442000 | USD |
| CY2014Q4 | fbio |
Deferred Tax Assets Amortization Of Upfront Fees
DeferredTaxAssetsAmortizationOfUpfrontFees
|
2668000 | USD |
| CY2015Q4 | fbio |
Deferred Tax Assets Amortization Of In Process Research And Development
DeferredTaxAssetsAmortizationOfInProcessResearchAndDevelopment
|
599000 | USD |
| CY2014Q4 | fbio |
Deferred Tax Assets Amortization Of In Process Research And Development
DeferredTaxAssetsAmortizationOfInProcessResearchAndDevelopment
|
525000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
8158000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
4512000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
210000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
518000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
4583000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
3856000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
|
358000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
|
0 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
72599000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
51053000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
50567000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
486000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
|
486000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.05 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.05 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.04 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.01 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.06 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.04 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0 | pure |
| CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7762000 | USD |
| CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18097000 | USD |
| CY2015Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12964000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6582000 | USD |
| CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4763000 | USD |
| CY2014Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4346000 | USD |
| CY2014Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4961000 | USD |
| CY2015Q1 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-464000 | USD |
| CY2015Q2 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
1344000 | USD |
| CY2015Q3 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-1783000 | USD |
| CY2015Q4 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-2449000 | USD |
| CY2014Q1 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
-788000 | USD |
| CY2014Q2 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
52000 | USD |
| CY2014Q4 | fbio |
Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
|
1248000 | USD |
| CY2015Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
479000 | USD |
| CY2015Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
243000 | USD |
| CY2015Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
1694000 | USD |
| CY2015Q4 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
3039000 | USD |
| CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12056000 | USD |
| CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6175000 | USD |
| CY2015Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18161000 | USD |
| CY2015Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12036000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7370000 | USD |
| CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4711000 | USD |
| CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4592000 | USD |
| CY2014Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3713000 | USD |
| CY2015Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.31 | |
| CY2015Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.16 | |
| CY2015Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.46 | |
| CY2015Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.30 | |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | |
| CY2014Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.13 | |
| CY2014Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.13 | |
| CY2014Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
| CY2015 | us-gaap |
Loss Contingency Loss In Period
LossContingencyLossInPeriod
|
1000000 | USD |
| CY2015Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2015Q3 | fbio |
Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
|
2500 | shares |
| CY2015Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
7.00 | |
| CY2015Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
10000 | shares |
| CY2015Q3 | fbio |
Stock Issued During Period Value Of Warrants Excercised
StockIssuedDuringPeriodValueOfWarrantsExcercised
|
50000 | USD |
| CY2013 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
136000 | USD |
| CY2015Q4 | fbio |
Accrued Expenses Releted To Dr Falk Pharma Milestone
AccruedExpensesReletedToDrFalkPharmaMilestone
|
2717000 | USD |
| CY2015 | fbio |
Percentage Of Cash Flow Pursuant To Asc470
PercentageOfCashFlowPursuantToAsc470
|
0.1 | pure |
| CY2015 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1500000 | USD |
| CY2014 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1300000 | USD |
| CY2013 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1900000 | USD |
| CY2015Q4 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
300000 | USD |
| CY2015 | us-gaap |
Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
|
7500000 | USD |
| CY2015 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
66700000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
7500000 | USD |
| CY2015Q4 | fbio |
Value Of Warrants Issued
ValueOfWarrantsIssued
|
600000 | USD |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.44 | pure |
| CY2015Q4 | us-gaap |
Deferred Tax Liabilities Parents Basis In Discontinued Operation
DeferredTaxLiabilitiesParentsBasisInDiscontinuedOperation
|
5869000 | USD |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
|
0.03 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
|
0 | pure |
| CY2015 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
16200000 | USD |
| CY2015 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
23700000 | USD |
| CY2015Q4 | us-gaap |
Investment Owned At Fair Value
InvestmentOwnedAtFairValue
|
2200000 | USD |
| CY2015Q4 | fbio |
Warrants Issued
WarrantsIssued
|
139592 | shares |
| fbio |
Value Of Warrants Issued
ValueOfWarrantsIssued
|
200000 | USD | |
| CY2014Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
243000 | USD |
| CY2015 | us-gaap |
Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
10448000 | USD |
| CY2014 | us-gaap |
Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
0 | USD |
| CY2013 | us-gaap |
Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
0 | USD |
| CY2015 | fbio |
Payment For Research And Development Licenses
PaymentForResearchAndDevelopmentLicenses
|
10448000 | USD |
| CY2014 | fbio |
Payment For Research And Development Licenses
PaymentForResearchAndDevelopmentLicenses
|
0 | USD |
| CY2013 | fbio |
Payment For Research And Development Licenses
PaymentForResearchAndDevelopmentLicenses
|
0 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
66730000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
5869000 | USD |
